🇺🇸

US SEC Filing Intelligence

· daily

Dow Jones 30 Stocks SEC Filings — May 29, 2026

The 50 filings from Dow 30 constituents and related entities reveal a bifurcated market: strong consumer spending driving Walmart's 7.3% revenue growth contrasts with significant distress in the SPAC and pre-revenue biotech sectors, where multiple companies face going-concern warnings and Nasdaq non-compliance. Capital allocation trends show a preference for share buybacks ($2.08B at Walmart) and debt refinancing (Navient's $500M 9.375% notes), while insider activity is notably absent across the sample. The most material developments include the completion of Calavo Growers' acquisition by Mission Produce (10/10 materiality), the rejection of Enveric Biosciences' authorized stock increase proposal, and multiple Nasdaq compliance issues at Fathom Holdings, Onfolio Holdings, and BullFrog AI. Period-over-period data is limited but revealing: Viasat's revenue grew 3% YoY but margins compressed 200 bps, while Hallmark Venture Group improved its net loss by 62.5% YoY from a zero-revenue base. The overall sentiment skews neutral-to-mixed, with 10 filings showing mixed sentiment, 4 positive, 3 negative, and the remainder neutral, indicating a cautious market environment with selective opportunities in companies demonstrating operational improvement.

25 high priority 25 medium 50 total filings
· daily

US SEC Filings Daily Market Digest — May 29, 2026

Today's filing digest is dominated by significant M&A activity and capital market transactions, alongside a flurry of annual meeting results. The most impactful deal is GameStop's non-binding, $125/share proposal to acquire eBay, a high-risk, high-reward gamble that has introduced massive optionality into GME's stock. Two major acquisitions closed: Mission Produce's purchase of Calavo Growers (creating a North American avocado powerhouse) and Nano Nuclear Energy's acquisition of Secured Transportation Services (adding immediate revenue and nuclear logistics capabilities). On the capital markets front, AGNC Investment Corp. registered a massive $2B ATM program, Peabody Energy priced $225M in convertible notes, and Tiptree Inc. closed its sale of Fortegra, returning significant cash to its balance sheet and authorizing a $20M buyback. Several low-market-cap companies executed reverse stock splits to maintain exchange listings, signaling ongoing distress. While numerous annual meeting filings confirm routine director elections and auditor ratifications, several revealed notable shareholder dissent on executive compensation, particularly at Bandwidth (24.5% against) and Maplebear (21.2% against), indicating growing investor scrutiny on pay-for-performance alignment.

22 high priority 28 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — May 29, 2026

The S&P 500 Consumer Discretionary sector presents a mixed picture across 50 filings, with dominant themes including significant insider selling through shareholder dissent at annual meetings, operational restructuring in challenged legacy brands, and aggressive capital deployment by market leaders. Walmart's standout Q1 FY27 performance (revenues +7.3% YoY to $177.8B, net income +18.8%) contrasts sharply with the deterioration at FingerMotion (-32% revenue decline) and Rocky Mountain Chocolate Factory (-7% revenue despite margin improvement). The sector shows a bifurcation between scale winners investing heavily ($6.68B capex at Walmart, +34.1% YoY) and smaller caps facing existential liquidity or compliance risks (Fathom Holdings, Onfolio Holdings, Gulf Resources all receiving Nasdaq delisting notices). M&A activity is limited but notable, with FONAR's going-private merger approval and Faraday Future's strategic pivot to robotics representing unconventional moves. Capital allocation is polarized—Walmart returned $4.05B via dividends/buybacks while several micro-caps remain cash-constrained. The most actionable insights cluster around Walmart's operational momentum, Rocky Mountain's restructuring inflecting, and risk flags at numerous non-compliant entities.

22 high priority 28 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — May 29, 2026

The 38 filings for the S&P 500 Healthcare stream reveal a sector bifurcated between established firms with stable capital returns and small-cap biotechs facing severe liquidity pressures. Period-over-period trends are limited due to the absence of financial results in most filings, but notable patterns include significant insider trading signals (e.g., CFO departures, board restructuring) and a high incidence of negative sentiment among cash-strapped development-stage companies. Key themes include aggressive capital structure changes (authorized stock increases, reverse splits), ongoing litigation and regulatory risks (FDA warning letters, shareholder lawsuits), and a flurry of annual meeting votes with notable dissent on director elections and compensation plans. The most critical developments are the existential threats to Pacific Coast Oil Trust (no distributions, cumulative deficits) and CID Holdco (employee furlough, convertible note with OID), while positive signals come from BD's resumption of ChloraPrep shipments and Skye Bioscience's authorized stock increase. Investors should monitor the upcoming catalyst calendar, including the Principal Exchange-Traded Funds special meeting on June 25 and the Financial Investors Trust reconvened meeting on July 2.

10 high priority 28 medium 38 total filings
· daily

US Executive Compensation Proxy SEC Filings — May 29, 2026

This batch of 12 proxy filings reveals a market dominated by SPACs and small-cap companies facing existential liquidity and governance challenges. A key theme is the aggressive use of shareholder votes to authorize dilutive financing (reverse splits, below-market placements, and share issuance for acquisitions) to stave off liquidation or fund operations. Insider activity is notably absent across most filings, suggesting a lack of management conviction, while several companies are undergoing significant board restructuring following private placements. The most critical developments are the high-risk votes at Quartzsea Acquisition Corp (liquidation risk), Nuvve Holding Corp (dilution risk), and Alpha Star Acquisition Corp (negative tangible book value), all of which present binary outcomes for investors. Period-over-period comparisons were largely unavailable in these governance-focused filings, but the forward-looking data on capital structure changes provides a clear catalyst calendar for the next 30 days.

12 high priority 12 total filings
· daily

US IPO Pipeline SEC S-1 Filings — May 29, 2026

The IPO pipeline digest for May 29, 2026 reveals a bifurcated market: two blank-check companies (SPACs) are raising $200M and $100M despite no identified targets, signaling persistent appetite for speculative vehicles, while de-SPAC and small-cap issuers show significant distress. Kodiak AI's S-1, filed post-business combination, highlights serious liquidity constraints with $10M of SAFE loans unconverted and no draw on a $20M facility, yet it secured $205M in new equity, suggesting a high-risk/high-reward profile. BullFrog AI embodies micro-cap peril—a going concern with Nasdaq non-compliance on bid price and a pending August 10 deadline—offset only by a one-year feasibility agreement with a large pharma. PEBO's S-4 merger, with a fixed exchange ratio and limited OTC market for the target, carries integration risk but may appeal to value-oriented investors. Across the five filings, there is a clear absence of insider buying signals (none reported), heavy reliance on forward-looking feasibility and earn-outs, and a dominant theme of capital-constrained entities using registered offerings to stabilize or exit. No period-over-period revenue or margin comparisons were available in these pre-revenue or shell-company filings, limiting trend analysis but underscoring the speculative nature of this pipeline.

5 high priority 5 total filings
· daily

Global High-Priority Regulatory Events — May 29, 2026

The May 29, 2026, filing stream reveals a market bifurcated between aggressive corporate action and systemic governance failures. A wave of transformative M&A, including GameStop's audacious $125/share bid for eBay and Mission Produce's completed acquisition of Calavo Growers, signals a high-risk, high-reward appetite for consolidation, particularly in sectors with tangible assets and supply chain synergies. Concurrently, a severe governance crisis is unfolding among Indian state-linked and smaller entities, with multiple fines for non-compliance with independent director requirements (Bharat Dynamics, Gujarat State Financial, GTT Data Solutions) highlighting a structural weakness in board composition. The financial results paint a stark picture: while Okta and Copart show steady, if decelerating, growth, the Indian aviation sector is in turmoil, with IndiGo swinging to a massive FY26 net loss of ₹23,936 million from a ₹72,584 million profit, driven by crippling forex losses. Insider activity is muted, but the creation of a massive ₹12,113 crore pledge by Adani Power on Jaiprakash Power Ventures shares is a critical development, signaling complex financial engineering within the resolution of a stressed asset. The overarching theme is one of aggressive capital deployment for growth and resolution, clashing with deep-seated regulatory and operational risks in specific geographies and sectors.

50 high priority 50 total filings
· daily

US Earnings Financial Results SEC Filings — May 29, 2026

The 32 filings reveal a bifurcated market where large-cap tech and select industrials (HEICO, Autodesk, MongoDB) are delivering robust growth and margin expansion, while consumer-facing and small-cap names (Target, Toll Brothers, FingerMotion, Stemtech) face significant headwinds. Revenue growth is a key differentiator: Snowflake (+33.5% YoY), MongoDB (+25.3%), and Autodesk (+18.4%) lead, contrasting with declines at FingerMotion (-32%), Stemtech (-43%), and Norris Industries (-13%). Margin trends are equally divergent, with TJX and Gap showing strong operating leverage, while Target and Toll Brothers suffer from cost inflation and impairment charges. Insider activity is sparse but notable, with no major buying or selling patterns detected. Capital allocation is aggressive at the top end, with Walmart, Copart, and Gap executing large buybacks, while distressed micro-caps like Nutra Pharma and Stemtech are issuing shares for debt settlement. The most critical development is the divergence in consumer health: Walmart's 7.3% revenue growth signals strength in value retail, while Target's 22.9% operating income decline and Toll Brothers' 26.1% net income drop suggest pressure on discretionary and higher-end spending. The portfolio-level pattern is a 'flight to quality' favoring companies with recurring revenue, strong free cash flow, and pricing power.

32 high priority 32 total filings
· daily

US SEC Trading Suspension Halt Orders — May 29, 2026

This intelligence digest synthesizes 9 pre-analyzed SEC filings from May 29, 2026, all concerning trading suspensions and delisting risks on US exchanges. A dominant theme is the widespread failure to meet Nasdaq's minimum stockholders' equity requirement, with three companies (Aditxt, Onfolio, HWH International) reporting negative or critically low equity, and a fourth (Actinium Pharmaceuticals) falling short of NYSE American's $4.0 million threshold. Another cluster involves delayed periodic filings (Fathom, Gulf Resources, Clean Energy Technologies, Cloudastructure), indicating systemic reporting control issues. The most acute risk is for Edible Garden AG, which faces an imminent suspension on June 5, 2026, due to ineligibility for a compliance period after multiple reverse stock splits. While most filings carry negative sentiment, Actinium Pharmaceuticals presents a mixed picture, balancing a delisting notice with a positive clinical program update, offering a potential turnaround catalyst. The aggregate data reveals a micro-cap distress pattern, with all affected companies having market capitalizations well below $100 million and exhibiting negative equity or recurring losses, signaling a high-risk environment for investors in this segment.

9 high priority 9 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 29, 2026

The 49 filings reveal a surge in corporate distress signals, with 10 companies receiving Nasdaq non-compliance or delisting notices, primarily due to late filings or equity deficiencies. Notable distress includes Aditxt (negative equity of -$35M), Edible Garden (imminent suspension), and Gulf Resources (multiple delinquencies). Capital markets activity is mixed: several companies raised debt (Xylem $1B, Kennedy-Wilson $1.8B, Navient $500M) or equity (Momentus $25M, Wellgistics $21.1M), while others like GrafTech and Solana expanded ATM programs. M&A activity continues with Cycurion acquiring Secuvant for $3M, CoStar buying Zonda for $800M, and Healthy Choice Wellness acquiring Host Digital. Insider trading data is sparse, but the high number of going concern warnings and equity issuances suggests management caution. Period-over-period comparisons are limited as most filings are event-driven, but Avalanche Treasury's net loss of $139,635 and zero cash highlight severe cash burn. The overall theme is a bifurcated market: well-capitalized firms access debt markets cheaply, while distressed micro-caps scramble for survival.

49 high priority 49 total filings
· daily

US Executive Officer Management Changes SEC — May 29, 2026

The 39 filings for May 29, 2026 reveal a significant surge in annual meeting outcomes and board/executive transitions, with a strong undercurrent of shareholder activism and financial strain. A notable 18 filings involve shareholder meetings where diverse proposals, including equity plan amendments and reverse stock splits, were passed, but several saw material dissent (e.g., Enveric's rejected stock increase, Nu Skin's narrow 70% approval on incentive plan). The sector shows a distinct pattern of insider transitions (CFO changes at Cencora, Jazz Pharma, LENSAR, and departures at Spire and Outset Medical), often structured with lengthy transition periods and advisory roles to ensure continuity. Critically, CID Holdco presents a high-risk distress signal with a temporary employee furlough, a dilutive convertible note (20% OID), and salary deferrals by executives, contrasting sharply with the stability indicated by ScanSource's YoY revenue and margin growth. The data strongly suggests a bifurcated market where stable, profitable companies are executing smooth leadership changes and rewarding shareholders, while cash-burning entities face governance challenges and existential liquidity pressures. Insider activity is absent, but forward-looking statements from Cencora (reaffirmed guidance) and the catalyst calendar from LENSAR's upcoming AGM provide actionable intelligence.

39 high priority 39 total filings
· daily

US Corporate Board Director Changes SEC Filings — May 29, 2026

The 39 filings from May 29, 2026, primarily cover board and executive transitions (CEO, CFO, COO, director resignations/appointments), annual meeting results, and equity plan amendments. A key theme is significant insider turnover and board refreshment, which is largely neutral but includes some worrying departures (e.g., CID Holdco's entire employee furlough) and bullish stability in cash-rich firms like Cencora. Period-over-period comparisons from filings (ScanSource, Cencora) reveal modest revenue growth (2% YoY for ScanSource) and stable guidance (Cencora), but a notable number of companies (Enveric, Nu Skin, indie Semi) saw equity plan approvals face shareholder dissent, indicating governance friction. The most critical development is the severe financial distress at CID Holdco, which has furloughed all employees amid a liquidity crisis, presenting an extreme risk flag. Sector themes include a move toward majority voting for directors (First Interstate), a trend of insider talent migration from departing roles (Spire Global), and a cautious capital allocation environment with dividends holding at ScanSource.

39 high priority 39 total filings
· daily

US Merger & Acquisition SEC Filings — May 29, 2026

The May 29, 2026, US M&A landscape is dominated by the consummation of the transformative Mission Produce/Calavo Growers merger, creating a dominant North American avocado and fresh produce powerhouse, while a flurry of SPAC activity signals a potential acceleration in de-SPAC transactions. Notable period-over-period trends include a clear bifurcation in capital allocation: Tiptree is aggressively returning capital via a new $20M buyback post-divestiture, while early-stage firms like Nano Nuclear and VERAXA are securing dilutive debt and equity financing to fund growth. Insider activity is sparse but notable, with a new board appointment at Averin Capital bringing deep healthcare expertise, suggesting a targeted acquisition search. Forward-looking statements create a catalyst-rich calendar, with critical shareholder votes for Live Oak/Teamshares (June 16) and the FG Merger II/BOXABL deal, alongside monthly extension deadlines for Constellation Acquisition Corp I. The most critical development is the Mission/Calavo close, which immediately removes a public company (Calavo) and creates a combined entity with significant integration risks and potential for margin expansion through synergies, a key theme for investors to monitor in the coming quarters.

12 high priority 12 total filings
· monthly

US Pre-Market SEC Filings Roundup — May 29, 2026

Overnight filings from May 28-29, 2026 reveal a market landscape defined by aggressive capital deployment and strategic repositioning, with M&A and capital allocation dominating the news flow. The most impactful development is GameStop's unsolicited $125/share bid for eBay, a high-stakes, non-binding proposal that introduces significant regulatory and execution risk. In the avocado sector, Mission Produce completed its transformative acquisition of Calavo Growers, creating a dominant North American player but carrying substantial integration risks. On the capital allocation front, Copart aggressively repurchased $1.63 billion in shares (reducing float by 4.3%), while WisdomTree bought back convertible notes at a 68% premium, and AGNC established a new $2 billion ATM program. Period-over-period data from quarterly reports shows mixed results: Okta delivered solid 11.2% revenue growth but saw deferred revenue decline, while Copart's revenue growth slowed to 2.1% with net income slightly down. Genesco posted a seventh consecutive quarter of positive comparable sales but remains unprofitable on a GAAP basis. A notable negative signal comes from Palermo Technologies' IPO, which is self-underwritten at an arbitrary $0.10/share with no minimum offering, and Nano Nuclear Energy's acquisition of a profitable nuclear transport firm for up to $13M provides a rare revenue-generating entry point in the microreactor space. Overall, the filings suggest a market where companies are actively reshaping their capital structures and competitive positions, but with mixed underlying operational momentum.

15 high priority 20 medium 35 total filings
· daily

VA Healthcare & Services Contracts — May 28, 2026

The single contract analyzed, a $70.6 million firm-fixed-price delivery order from the Department of Veterans Affairs to EMERGENT, LLC (a subsidiary of MYTHICS, INC.), represents a purely civilian IT services win with no defense exposure. The award, for an Oracle Enterprise License Agreement under full and open competition, signals a significant multi-year revenue stream for MYTHICS, with a potential total value of $162.9 million if all options are exercised through 2030. The highest-conviction signal is the stable, non-discretionary nature of VA IT spending, though the firm-fixed-price structure introduces high performance risk. Key watch items include option exercise timing and potential contract modifications that could affect revenue realization.

1 total filings
· daily

Significant Contract Modifications ($10M+) — May 28, 2026

This digest of 15 significant contract modifications, totaling $1.09 billion, reveals a purely civilian procurement landscape with zero defense-related awards, underscoring a pronounced shift in federal spending toward non-DOD agencies. The dominant themes are civilian IT modernization (GSA, DHS, State, VA) and health/biodefense R&D (HHS/BARDA), with the highest-conviction signal being Booz Allen Hamilton's $218.7M cost-plus-award-fee delivery order from GSA, which offers stable, low-risk revenue visibility. A key risk is the high concentration of awards to small, private, or nonprofit entities (e.g., Venatorx, V3GATE, Zen Strategics), limiting direct public market exposure, while the absence of defense contracts may signal a temporary lull or a broader civilian spending priority shift that warrants monitoring.

15 total filings
· daily

Contract Deobligations Alert — May 28, 2026

This digest of 15 government contracts, totaling $1.09 billion, is entirely civilian in nature, with zero defense-related awards. The dominant theme is IT modernization and professional services, led by Booz Allen Hamilton's $218.7M GSA engineering services award (potential $626.5M) and Venatorx Pharmaceuticals' $106.6M BARDA R&D contract. The highest-conviction signal is Booz Allen's cost-plus structure, which provides low-risk, stable revenue visibility. A key watch item is the high concentration of awards to small and privately-held firms (e.g., V3GATE, Four Points Technology, Zen Strategics), which limits direct public equity exposure and introduces execution risk on firm-fixed-price contracts.

15 total filings